Cargando…

Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India

Background Patients with major depressive disorder have varying response rates to treatment. Multiple factors such as non-adherence, comorbidity, chronic stressors, and biological factors may be responsible for this variation. Inflammatory (pro and anti) markers have been well studied as a cause for...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandal, Sucharita, Spoorthy, Mamidipalli Sai, Godi, Sangha Mitra, Nanda, Rachita, Mukherjee, Bhaskar, Mishra, Nihar Ranjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481369/
https://www.ncbi.nlm.nih.gov/pubmed/37680396
http://dx.doi.org/10.7759/cureus.43059
_version_ 1785101961415098368
author Mandal, Sucharita
Spoorthy, Mamidipalli Sai
Godi, Sangha Mitra
Nanda, Rachita
Mukherjee, Bhaskar
Mishra, Nihar Ranjan
author_facet Mandal, Sucharita
Spoorthy, Mamidipalli Sai
Godi, Sangha Mitra
Nanda, Rachita
Mukherjee, Bhaskar
Mishra, Nihar Ranjan
author_sort Mandal, Sucharita
collection PubMed
description Background Patients with major depressive disorder have varying response rates to treatment. Multiple factors such as non-adherence, comorbidity, chronic stressors, and biological factors may be responsible for this variation. Inflammatory (pro and anti) markers have been well studied as a cause for depression, predisposing factors, and a consequence of depression. Among these, interleukins (ILs), interferons, C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-α) have been studied repeatedly. We conducted a pilot study to assess the levels of these inflammatory markers in patients with major depressive disorder. The specific objectives of this study were to compare and correlate changes in pro- and anti-inflammatory markers throughout different phases of depression, including pretreatment and posttreatment periods, and to evaluate the pattern of pro- and anti-inflammatory markers in patients who experienced remission or showed a positive response to treatment. Methodology This was a prospective, clinic-based, cohort study done for a period of one and a half years. Patients aged 18-65 years with depressive disorder per the International Classification of Diseases Tenth Edition and who scored more than 7 on the Hamilton Depression Rating Scale were included in this study. A total of 81 patients were recruited who were followed up till eight weeks after inclusion. A total of 31 patients completed the eight weeks of follow-up. Levels of IL-10 and TNF-α were assessed at baseline, two weeks, four weeks, and eight weeks of follow-up. Results This study tried to compare the levels of pro- and anti-inflammatory markers across pretreatment and various posttreatment phases of depression. Results showed that the levels of pro-inflammatory cytokine TNF-α increased from baseline till eight weeks of follow-up, and levels of IL-10 decreased from baseline till eight weeks of follow-up. However, these changes were not statistically significant. Conclusions This study supports the hypothesis that inflammatory markers can be trait markers of depression rather than the consequence or result.
format Online
Article
Text
id pubmed-10481369
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104813692023-09-07 Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India Mandal, Sucharita Spoorthy, Mamidipalli Sai Godi, Sangha Mitra Nanda, Rachita Mukherjee, Bhaskar Mishra, Nihar Ranjan Cureus Psychiatry Background Patients with major depressive disorder have varying response rates to treatment. Multiple factors such as non-adherence, comorbidity, chronic stressors, and biological factors may be responsible for this variation. Inflammatory (pro and anti) markers have been well studied as a cause for depression, predisposing factors, and a consequence of depression. Among these, interleukins (ILs), interferons, C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-α) have been studied repeatedly. We conducted a pilot study to assess the levels of these inflammatory markers in patients with major depressive disorder. The specific objectives of this study were to compare and correlate changes in pro- and anti-inflammatory markers throughout different phases of depression, including pretreatment and posttreatment periods, and to evaluate the pattern of pro- and anti-inflammatory markers in patients who experienced remission or showed a positive response to treatment. Methodology This was a prospective, clinic-based, cohort study done for a period of one and a half years. Patients aged 18-65 years with depressive disorder per the International Classification of Diseases Tenth Edition and who scored more than 7 on the Hamilton Depression Rating Scale were included in this study. A total of 81 patients were recruited who were followed up till eight weeks after inclusion. A total of 31 patients completed the eight weeks of follow-up. Levels of IL-10 and TNF-α were assessed at baseline, two weeks, four weeks, and eight weeks of follow-up. Results This study tried to compare the levels of pro- and anti-inflammatory markers across pretreatment and various posttreatment phases of depression. Results showed that the levels of pro-inflammatory cytokine TNF-α increased from baseline till eight weeks of follow-up, and levels of IL-10 decreased from baseline till eight weeks of follow-up. However, these changes were not statistically significant. Conclusions This study supports the hypothesis that inflammatory markers can be trait markers of depression rather than the consequence or result. Cureus 2023-08-07 /pmc/articles/PMC10481369/ /pubmed/37680396 http://dx.doi.org/10.7759/cureus.43059 Text en Copyright © 2023, Mandal et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Psychiatry
Mandal, Sucharita
Spoorthy, Mamidipalli Sai
Godi, Sangha Mitra
Nanda, Rachita
Mukherjee, Bhaskar
Mishra, Nihar Ranjan
Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India
title Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India
title_full Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India
title_fullStr Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India
title_full_unstemmed Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India
title_short Inflammatory Markers in Patients With Major Depressive Disorder: A Prospective, Clinic-Based, Cohort Study From India
title_sort inflammatory markers in patients with major depressive disorder: a prospective, clinic-based, cohort study from india
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481369/
https://www.ncbi.nlm.nih.gov/pubmed/37680396
http://dx.doi.org/10.7759/cureus.43059
work_keys_str_mv AT mandalsucharita inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia
AT spoorthymamidipallisai inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia
AT godisanghamitra inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia
AT nandarachita inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia
AT mukherjeebhaskar inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia
AT mishraniharranjan inflammatorymarkersinpatientswithmajordepressivedisorderaprospectiveclinicbasedcohortstudyfromindia